Statement Of Changes In Equity [Abstract]

Zealand Pharma - Filing #5889383

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	—	6,157,441,000 DKK	14,680,771,000 DKK	—	71,024,000 DKK	22,388,000 DKK	—	—	8,616,742,000 DKK	—	1,592,839,000 DKK	4,894,841,000 DKK	—	—	—	6,406,225,000 DKK	—	58,751,000 DKK	22,704,000 DKK	815,911,000 DKK	4,921,232,000 DKK	4,171,640,000 DKK	51,702,000 DKK	14,617,000 DKK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	- DKK	- DKK	—	—	- DKK	—	—	1,078,828,000 DKK	1,078,828,000 DKK	—	703,739,000 DKK	—	—	703,739,000 DKK	- DKK	- DKK	—	- DKK	—	—	—	—	—	—	—
Comprehensive income	- DKK	- DKK	—	—	316,000 DKK	—	—	1,078,828,000 DKK	1,079,144,000 DKK	—	695,652,000 DKK	—	—	703,739,000 DKK	- DKK	8,087,000 DKK	—	- DKK	—	—	—	—	—	—	—
Issue of equity	12,112,000 DKK	8,480,559,000 DKK	—	—	- DKK	—	—	- DKK	8,492,671,000 DKK	—	1,500,000,000 DKK	—	—	- DKK	1,493,421,000 DKK	- DKK	—	6,579,000 DKK	—	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	- DKK	- DKK	—	—	- DKK	—	—	87,032,000 DKK	87,032,000 DKK	—	61,426,000 DKK	—	—	61,426,000 DKK	- DKK	- DKK	—	- DKK	—	—	—	—	—	—	—